Mast Cell Activation by Conidia of Sporothrix schenckii: Role in the Severity of Infection

Scandinavian Journal of Immunology

Volumn 76, Issue 1, 2012, Pages 11-20

  Romo Lozano, Y ^a   Hernandez Hernandez F ^b   Salinas, E ^a  

^a UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE SEVERITY; EXOCYTOSIS; HISTAMINE RELEASE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL; NONHUMAN; ORCHITIS; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS;

ANIMALS; CELL DEGRANULATION; CHI-SQUARE DISTRIBUTION; HISTAMINE; INTERLEUKIN-6; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, WISTAR; SPORES, FUNGAL; SPOROTHRIX; SPOROTRICHOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862259268     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02706.x     Document Type: Article

References (40)

1. López-Romero E, Reyes-Montes MR, Pérez-Torres A et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol 2011;6:85-102.
2. Nascimiento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporothrichosis. FEMS Immunol Med Microbiol 2005;43:241-7.
3. de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaesde Oliveira R, Martins EB, Teixeira JL, Wanke B. Treatment of cutaneous sporotrichosis with itraconazole - study of 645 patients. Clin Infect Dis 2011;52:200-6.
4. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999;37:397-404.
5. Kajiwara H, Saito M, Ohga S, Uenotsuchi T, Yoshida S. Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease. Infect Immun 2004;72:5073-9.
6. Uenotsuchi T, Takeuchi S, Matsuda T. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int Immunol 2006;18:1637-46.
7. de Lima Franco D, Nascimento RC, Ferreira KS, Almeida SR. Antibodies against Sporothrix schenckii enhance TNF-α production and killing by macrophages. Scand J Immunol 2011;75:142-6.
8. Galli SJ, Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 2008;49:7-19.
9. Abraham SN, St John A. Mast cell-orchestrated immunity to pathgens. Nat Rev Immunol 2010;10:440-52.
10. Pickett JA, Edwardson JM. Compound exocytosis: mechanism and functional significance. Traffic 2006;7:109-16.
11. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006;117:1214-25.
12. Urb M, Pouliot P, Gravelat FN, Oliver M, Sheppard DC. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J Infect Dis 2009;200:464-72.
13. Selander C, Engblom C, Nilsson G, Scheynius A, Andersson CL. TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol 2009;182:4208-16.
14. Olynych TJ, Jakeman DL, Marshall JS. Fungal zymosan induces leukotriene production by human mast cells through a dectin-1 dependent mechanism. J Allergy Clin Immunol 2006;118:837-43.
15. Yang Z, Marshall JS. Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology 2009;214:321-30.
16. Lagunoff D. Vital staining of mast cells with ruthenium red. J Histochem Cytochem 1972;20:938-44.
17. Kolaczkowska E, Letito M, Kozakiewcz E, van Rooijeb N, Plytycz B, Arnold B. Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells. Immunol Lett 2007;113:99-106.
18. González-Espinosa C, Odom S, Olivera A et al. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med 2003;197:1453-65.
19. Niide O, Suzuki Y, Yoshimaru T, Inoue T, Takayama T, Ra C. Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications for immunosuppressive activities. Clin Immunol 2006;118:108-16.
20. Nielsen EH, Clausen J. Electron microscopic study of the regeneration in vivo of rat peritoneal mast cells after histamine secretion. Cell Tissue Res 1982;224:465-8.
21. Ajuebor MN, Das AM, Virág L, Flower RJ, Szabó C, Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999;162:1685-91.
22. Carlos IZ, Sassá MF, da Graça Sgarbi DB, Placeres MC, Maia DC. Current research on the immune response to experimental sporotrichosis. Mycopathologia 2009;168:1-10.
23. Chan CY, St John AL, Abraham SN. Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol 2012;15:78-84.
24. McAlpine SM, Issekutz TB, Marshall JS. Virus stimulation of human mast cells results in the recruitment of CD56+ T cells by a mechanism dependent on CCR5 ligands. FASEB J 2011;26:1280-9.
25. Ponton J. The fungal cell wall and the mechanism of action of anidulafungin. Rev Iberoam Micol 2008;25:78-82.
26. da Silva AC, Bezerra LM, Aguilar TS et al. Effect of genetic modifications by selection for immunological tolerance on fungus infection in mice. Microbes Infect 2001;3:215-22.
27. Carlos IZ, Sgarbi DB, Santos GC, Placeres MC. Sporothrix schenckii lipid inhibit macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand J Immunol 2003;57:214-20.
28. Fernandes KS, Neto EH, Brito MM, Silva JS, Cunha FQ, Barja-Fidalgo C. Detrimental role of endogenous nitric oxide in host defense against Sporothrix schenckii. Immunology 2008;123:469-79.
29. Allendoerfer R, Deepe GS Jr. Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol 2000;165:2657-64.
30. Souto JT, Figueiredo F, Furlanetto A, Pfeffer K, Rossi MA, Silva JS. Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol 2000;156:1811-8.
31. Sassá MF, Ferreira LS, de Abreu Ribeiro LC, Carlos IZ. Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia, 2012, DOI: 10.1007/s11046-012-9523-1. [Epub ahead of print].
32. Hirano T. Interleukin 6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992;62:60-5.
33. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996;183:1345-55.
34. Mazonni A, Siraganian RP, Leifer CA, Segal DM. Dendritic cell modulatory by mast cells control the Th1/Th2 balance in responding T cells. J Immunol 2006;177:3577-81.
35. Carlos IZ, Zini MM, Sgarbi DB, Angluster J, Alviano CS, Silva CL. Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia 1994;127:198-94.
36. Gottlieb GS, Lesser CF, Holmes KK, Wald A. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Clin Infect Dis 2003;37:838-40.
37. Seeley EJ, Sutherland RE, Kim SS, Wolters PJ. Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice. J Leukoc Biol 2011;90:591-7.
38. Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ. Mast cells IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 2008;181:5598-605.
39. Larsen FO, Clementsen P, Hansen M et al. The indoor microfungus Trichoderma viride potentiates histamine release from human bronchoalveolar cells. APMIS 1996;104:673-9.
40. Holk P, Sletmoen M, Stokke BT, Permin H, Norn S. Potentiation of histamine release by microfungal (1→3)- and (1→6)-beta-D-glucans. Basic Clin Pharmacol Toxicol 2007;101:455-8.